StonvexLoading…
StonvexCore line items from NPO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $325.46M | $1.05B | $1.06B | $1.10B |
Operating Income | Not available | $142.30M | $76.80M | $72.20M |
Net Income | Not available | $72.90M | $22.20M | $205.10M |
EPS (Diluted) | $2.35 | $3.45 | $1.05 | $9.83 |
Total Assets | Not available | $2.49B | $2.50B | $2.65B |
Total Liabilities | Not available | $1.06B | $1.07B | $1.23B |
Cash & Equivalents | Not available | $236.30M | $369.80M | $334.40M |
Free Cash Flow OCF − CapEx | Not available | $133.80M | $174.50M | $76.70M |
Shares Outstanding | Not available | 21.10M | 21.00M | 20.90M |